Author

A. Rishi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

D. Tuveson· 2 shared J. Preall· 2 shared A. Álvarez-Arenas· 1 shared A. Habowski· 1 shared A. Karolak· 1 shared B. He· 1 shared C. Fan· 1 shared C. M. Perou· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Tuveson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 20, 2023

Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies to self-antigens

M. Yao, J. Preall, J. Yeh…·D. Fearon

The paper identifies auto-antibodies secreted by plasma cells in PDAC against self-antigens, suggesting a link between chronic inflammation and autoimmunity.

DOI 10.1101/2023.03.20.533453

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivAug 9, 2021

Patient-derived triple negative breast cancer organoids provide robust model systems that recapitulate tumor intrinsic characteristics

S. Bhatia, M. Kramer, S. Russo…·D. L. Spector

This study develops and characterizes patient-derived TNBC organoids that recapitulate tumor properties and identify key signaling pathways involved in cancer progression.

DOI 10.1158/0008-5472.can-21-2807

humanorganoid / primary culture

𝕏 PostBluesky

ImmunologybioRxivPreprintNov 16, 2018

Overcoming non-small cell lung cancer radiation resistance by modulating the tumor-immune ecosystem

S. Nizzero, J.C.L. Alfonso, A. Álvarez-Arenas…·H. Enderling

This paper proposes mathematical models to adapt radiotherapy plans based on tumor-immune ecosystem composition and immune responses to improve outcomes in non-small cell lung cancer.

DOI 10.1101/458372

humanstatistical model

𝕏 PostBluesky